| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | monoatomic anion transport | 2.75e-06 | 183 | 45 | 6 | GO:0006820 | |
| GeneOntologyBiologicalProcess | inorganic anion transport | 4.41e-05 | 180 | 45 | 5 | GO:0015698 | |
| GeneOntologyBiologicalProcess | microtubule-based process | 7.46e-05 | 1058 | 45 | 10 | GO:0007017 | |
| Domain | SSDP_DNA-bd | 1.70e-05 | 3 | 45 | 2 | IPR008116 | |
| Domain | LisH | 2.06e-03 | 28 | 45 | 2 | SM00667 | |
| Domain | LisH | 2.06e-03 | 28 | 45 | 2 | IPR006594 | |
| Domain | LISH | 2.06e-03 | 28 | 45 | 2 | PS50896 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 1.34e-06 | 861 | 45 | 9 | 36931259 | |
| Pubmed | NFAT5 Deficiency Alleviates Formalin-Induced Inflammatory Pain Through mTOR. | 1.64e-06 | 2 | 45 | 2 | 33806698 | |
| Pubmed | mTOR regulates the nucleoplasmic diffusion of Xrn2 under conditions of heat stress. | 1.64e-06 | 2 | 45 | 2 | 25128458 | |
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 12079286 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 29956771 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 32207633 | ||
| Pubmed | 4.56e-05 | 8 | 45 | 2 | 20301543 | ||
| Pubmed | 8.94e-05 | 11 | 45 | 2 | 26965372 | ||
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 9.54e-05 | 184 | 45 | 4 | 32908313 | |
| Pubmed | 1.07e-04 | 12 | 45 | 2 | 27782176 | ||
| Pubmed | 1.56e-04 | 209 | 45 | 4 | 36779422 | ||
| Pubmed | 2.40e-04 | 234 | 45 | 4 | 36243803 | ||
| Pubmed | TIF1gamma controls erythroid cell fate by regulating transcription elongation. | 2.47e-04 | 18 | 45 | 2 | 20603019 | |
| Pubmed | 2.47e-04 | 18 | 45 | 2 | 20602751 | ||
| Pubmed | 2.72e-04 | 446 | 45 | 5 | 24255178 | ||
| Pubmed | Association of IFIH1 and other autoimmunity risk alleles with selective IgA deficiency. | 3.72e-04 | 22 | 45 | 2 | 20694011 | |
| Pubmed | 4.42e-04 | 1429 | 45 | 8 | 35140242 | ||
| Pubmed | A chemical tool for blue light-inducible proximity photo-crosslinking in live cells. | 4.82e-04 | 25 | 45 | 2 | 35211260 | |
| Pubmed | 6.46e-04 | 130 | 45 | 3 | 12421765 | ||
| Pubmed | Control of developmentally primed erythroid genes by combinatorial co-repressor actions. | 6.96e-04 | 30 | 45 | 2 | 26593974 | |
| Pubmed | Elucidation of the BMI1 interactome identifies novel regulatory roles in glioblastoma. | 8.63e-04 | 329 | 45 | 4 | 34316702 | |
| Pubmed | 9.04e-04 | 146 | 45 | 3 | 21399614 | ||
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 9.14e-04 | 583 | 45 | 5 | 29844126 | |
| Coexpression | GSE9650_NAIVE_VS_EFF_CD8_TCELL_UP | 2.10e-05 | 200 | 44 | 5 | M5819 | |
| Coexpression | GSE3982_MAST_CELL_VS_TH2_DN | 2.10e-05 | 200 | 44 | 5 | M5456 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-05 | 158 | 45 | 4 | 1d78578dc1f8ba43dacdccae1082c0b9d749f64d | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.60e-05 | 170 | 45 | 4 | 6c65ddb496030bb479ef346cc37a9d4dfa6b824f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.39e-05 | 182 | 45 | 4 | 3d7a8d2ee2137b098248597058974ef5ae09c19e | |
| ToppCell | NS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.01e-05 | 190 | 45 | 4 | 250ca4a605c1cccd77d23383e4fe6f91cf3609ba | |
| ToppCell | mLN-ILC|mLN / Region, Cell class and subclass | 4.80e-05 | 199 | 45 | 4 | d6c299312c747fb1b7c53644c53efc03a5fffe85 | |
| ToppCell | mLN-(3)_ILC|mLN / shred on region, Cell_type, and subtype | 4.80e-05 | 199 | 45 | 4 | 00e0e2a766dd9c4d0a65f53d88fa50df4b6a3d60 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 4.80e-05 | 199 | 45 | 4 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | mLN-(3)_ILC-(30)_ILC|mLN / shred on region, Cell_type, and subtype | 4.80e-05 | 199 | 45 | 4 | 33ac6d77099076df01299be429f4ba96f2f34cc1 | |
| ToppCell | mLN-ILC-ILC|mLN / Region, Cell class and subclass | 4.80e-05 | 199 | 45 | 4 | ab09a06cdea2597e9fe4b4b304655e9de4d433f6 | |
| ToppCell | (3)_ILC|World / shred on Cell_type and subtype | 4.89e-05 | 200 | 45 | 4 | 03554b3f323785b1e0b48fa32de0d92065dd798e | |
| ToppCell | Transverse-(3)_ILC-(30)_ILC|Transverse / shred on region, Cell_type, and subtype | 4.89e-05 | 200 | 45 | 4 | 528520dc98775aca6cc7568fedf5906ea55e0bea | |
| ToppCell | Transverse-(3)_ILC|Transverse / shred on region, Cell_type, and subtype | 4.89e-05 | 200 | 45 | 4 | c1ad7cb012e1c8911e417f7d64ca662c4f5010e0 | |
| ToppCell | Transverse-ILC|Transverse / Region, Cell class and subclass | 4.89e-05 | 200 | 45 | 4 | eb04d6ad2270d3d9ac3d1fae1bb9bedc6fca38fe | |
| ToppCell | Transverse-ILC-ILC|Transverse / Region, Cell class and subclass | 4.89e-05 | 200 | 45 | 4 | 60ec185df2f1989bf8febf75b11c46a576829be3 | |
| ToppCell | (30)_ILC|World / shred on Cell_type and subtype | 5.29e-05 | 204 | 45 | 4 | bd9fbd278c05e396463704d711b60d47699e3c09 | |
| Drug | Benfotiamine [22457-89-2]; Down 200; 8.6uM; PC3; HT_HG-U133A | 1.91e-06 | 194 | 44 | 6 | 4312_DN | |
| Disease | Epidermolysis Bullosa Simplex | 2.17e-05 | 5 | 44 | 2 | C0079298 | |
| Disease | epidermolysis bullosa simplex (is_implicated_in) | 4.54e-05 | 7 | 44 | 2 | DOID:4644 (is_implicated_in) | |
| Disease | clinical and behavioural ideal cardiovascular health | 5.39e-04 | 23 | 44 | 2 | EFO_0007654 | |
| Disease | sugar consumption measurement | 7.69e-04 | 120 | 44 | 3 | EFO_0010158 | |
| Disease | Large cell carcinoma of lung | 1.05e-03 | 32 | 44 | 2 | C0345958 | |
| Disease | granulocyte colony-stimulating factor measurement | 1.18e-03 | 34 | 44 | 2 | EFO_0008142 | |
| Disease | Thyroid carcinoma | 1.98e-03 | 44 | 44 | 2 | C0549473 | |
| Disease | serum metabolite measurement | 2.65e-03 | 945 | 44 | 6 | EFO_0005653 | |
| Disease | glucose-dependent insulinotropic peptide measurement | 2.85e-03 | 53 | 44 | 2 | EFO_0008464 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YLSDTEESNMICQTM | 1616 | O94986 | |
| DQNTAVSSMSMTAQY | 151 | A6NCI8 | |
| QMESMTYSTERKTNS | 631 | Q2M3G0 | |
| ESEYMAQTQSTNHMI | 396 | Q8N8E3 | |
| YMLNTLTSNMSQLHS | 201 | Q5T5X7 | |
| DVQTQQMEDTMSSTT | 126 | Q7LBR1 | |
| NMNQVYSMSSTYIDK | 1156 | Q03001 | |
| VTSIEQISEMNMDYT | 91 | Q9UN88 | |
| TSPLYNMTNMNVATA | 291 | Q5W064 | |
| SATTTLENYLMEMQF | 96 | A1A4Y4 | |
| INLTNSGEDSYMTSM | 856 | P38570 | |
| MSVNSDQTLTTENMT | 1316 | Q8NEV8 | |
| MYMTDSNDTISNGTN | 516 | Q7L985 | |
| VYQQTSHMMSALSTN | 931 | O94916 | |
| YSSLMKVENMSSNQD | 186 | Q86WR0 | |
| MLLSMQTQDQSILYA | 81 | Q8NGS1 | |
| EYVMPMNTQLTSEST | 76 | Q9UF02 | |
| MLSQSVSSQYNMAGV | 191 | P54105 | |
| SDSSLQRQVMSNMYQ | 386 | Q9BX69 | |
| ESTVQMNYVSNVSKS | 56 | P16591 | |
| STLNQSAMMETLYSD | 186 | Q6P2H3 | |
| TYTQSMNTVLVQEMG | 3776 | Q8WXX0 | |
| SQNTSMSSIYQNCAM | 1471 | Q5VZ89 | |
| TSQDMQSLDMLSQDT | 376 | Q96JA4 | |
| TQMTNIGVYVSNMTD | 306 | Q8NA54 | |
| QNSMYMRQLSDLEST | 311 | Q5M9N0 | |
| MSTYKEAETQNTTLN | 366 | Q8TDX9 | |
| SSDYSTSEMLVNMGN | 926 | P42345 | |
| STNSGDNMYTLMNAV | 261 | P81877 | |
| NYSMVNTTNMTSAVV | 176 | P30531 | |
| SYVTIQNSELMSGSM | 636 | O14802 | |
| YSEMDVMSTATQHQT | 1421 | Q9P2F8 | |
| YSLTMQSSVTVQEGM | 26 | Q9Y286 | |
| NSTYNETNLMTTTEM | 481 | Q8N695 | |
| SGSYMNSMLTQIERQ | 36 | P46721 | |
| NLTTMYELESSRSMQ | 696 | Q8WVT3 | |
| KTSTSNVEQYQAMVT | 956 | P12270 | |
| DSTNSSENMYTIMNP | 281 | Q9BWG4 | |
| AYEMRMQNNSSPSIS | 461 | Q9H0D6 | |
| NINMQSYSVEMPTVS | 431 | Q9Y2X9 | |
| TFESNNEQTIMTMLQ | 511 | Q8WWQ8 | |
| LMTEYSQEQLNTMTS | 1291 | Q68DE3 | |
| YTATEQEMQQQMSLG | 181 | Q14142 | |
| SVAYSSNQTMGSQMV | 586 | Q9BYP7 | |
| QSEDMLTVQSYNTVT | 411 | Q9P2K6 |